Active substance
Results for the substance tasonermine
1 result
About this active substance
Tasonermin is a recombinant form of tumor necrosis factor-alpha (TNF-alpha) used in the treatment of certain types of cancer, such as malignant melanoma and soft tissue sarcoma. It works by stimulating the body's immune response against tumor cells.
The medication is administered via intravenous infusion, usually as part of an isolated limb perfusion protocol. It is important that the treatment is carried out under the supervision of a specialist doctor.
Patients should be aware of potential side effects, such as fever, chills, or reactions at the infusion site. It is important to inform the doctor of any unusual symptoms.
Common side effects include fever, nausea, fatigue, and low blood pressure. In rare cases, severe reactions such as capillary leak syndrome or systemic toxicity may occur. Patients should be informed of these risks before starting treatment.
The medication is administered via intravenous infusion, usually as part of an isolated limb perfusion protocol. It is important that the treatment is carried out under the supervision of a specialist doctor.
Patients should be aware of potential side effects, such as fever, chills, or reactions at the infusion site. It is important to inform the doctor of any unusual symptoms.
Common side effects include fever, nausea, fatigue, and low blood pressure. In rare cases, severe reactions such as capillary leak syndrome or systemic toxicity may occur. Patients should be informed of these risks before starting treatment.